Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Meyerle

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Translational Medicine|July 19, 2011
Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degenerationBaoying Liu, Lai Wei, Catherine Meyerle, et al.
Retina (Philadelphia, Pa.)|September 18, 2010
A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularizationRobert B Nussenblatt, Gordon Byrnes, H Nida Sen, et al.
Eye (London, England)|July 11, 2018
Gender variation in central serous chorioretinopathyDaren Hanumunthadu, Elon H C Van Dijk, Sankeert Gangakhedkar, et al.
Journal of Ophthalmic & Vision Research|May 23, 2019
Evaluation of Choroidal Layer Thickness in Central Serous ChorioretinopathyDaren Hanumunthadu, Elon H C van Dijk, Sunila Dumpala, et al.
American Journal of Ophthalmology|March 3, 2018
Shortest Distance From Fovea to Subfoveal Hemorrhage Border Is Important in Patients With Neovascular Age-related Macular DegenerationSaleema Kherani, Adrienne W Scott, Adam S Wenick, et al.
Retina (Philadelphia, Pa.)|June 26, 2015
OUTCOMES OF TREATMENT OF CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY WITH INTRAVITREAL ANTIANGIOGENIC AGENTSJay Chhablani, Igor Kozak, Francesco Pichi, et al.
American Journal of Ophthalmology|April 8, 2019
Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular EdemaMustafa Iftikhar, Tahreem A Mir, Gulnar Hafiz, et al.
Ophthalmology|December 30, 2015
Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein OcclusionTahreem A Mir, Saleema Kherani, Gulnar Hafiz, et al.
American Journal of Ophthalmology|May 1, 2016
Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex TrialPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
American Journal of Ophthalmology|August 27, 2016
ReplyPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Translational Medicine|July 19, 2011
Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degenerationBaoying Liu, Lai Wei, Catherine Meyerle, et al.
Retina (Philadelphia, Pa.)|September 18, 2010
A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularizationRobert B Nussenblatt, Gordon Byrnes, H Nida Sen, et al.
Eye (London, England)|July 11, 2018
Gender variation in central serous chorioretinopathyDaren Hanumunthadu, Elon H C Van Dijk, Sankeert Gangakhedkar, et al.
Journal of Ophthalmic & Vision Research|May 23, 2019
Evaluation of Choroidal Layer Thickness in Central Serous ChorioretinopathyDaren Hanumunthadu, Elon H C van Dijk, Sunila Dumpala, et al.
American Journal of Ophthalmology|March 3, 2018
Shortest Distance From Fovea to Subfoveal Hemorrhage Border Is Important in Patients With Neovascular Age-related Macular DegenerationSaleema Kherani, Adrienne W Scott, Adam S Wenick, et al.
Retina (Philadelphia, Pa.)|June 26, 2015
OUTCOMES OF TREATMENT OF CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY WITH INTRAVITREAL ANTIANGIOGENIC AGENTSJay Chhablani, Igor Kozak, Francesco Pichi, et al.
American Journal of Ophthalmology|April 8, 2019
Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular EdemaMustafa Iftikhar, Tahreem A Mir, Gulnar Hafiz, et al.
Ophthalmology|December 30, 2015
Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein OcclusionTahreem A Mir, Saleema Kherani, Gulnar Hafiz, et al.
American Journal of Ophthalmology|May 1, 2016
Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex TrialPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
American Journal of Ophthalmology|August 27, 2016
ReplyPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Pageof 3